Abstract
In a recent paper, Schaefer et al. proposed to enhance autonomy via improving reasoning abilities through (genetic) cognitive enhancement [1]. While initially their idea additionally seems to elegantly avoid objections against genetic enhancements based on the value of autonomy, we want to draw attention to several problems their approach poses. First, we will show that it is not at all clear that safe and meaningful methods to genetically or pharmaceutically enhance cognition will be feasible any time soon. Second, we want to provide a deeper discussion of the role of cognition and reasoning abilities in philosophical concepts of autonomy, as discussed in the mentioned paper. In doing so, we wish to demonstrate that using reasoning abilities as the common denominator in different accounts of autonomy in the context of enhancement does not do justice to the highly complex interrelations between cognition, reasoning abilities and autonomy. Neither should this way of arguing be accepted as a basis to call for practical outcomes, such as funding research into e. g. genetic cognitive enhancements, if the examined concepts of autonomy are taken seriously.
Similar content being viewed by others
Notes
Savulescu and Persson used this technique to identify altruism as a core feature of morality: aiming to later enhance morality by enhancing altruism [8]. To support their analysis, they refer to Christianity, Confucianism, Buddhism and the moral philosophies of Arthur Schopenhauer and David Hume, which all seem to rely on altruism as a core feature of morality. Sparrow [36] has highlighted the irony of this particular paper by Savulescu and Persson, which justifies the need for biomedical moral enhancement to address the potential dangers that may result from implementation of the cognitive enhancement Savulescu and colleagues usually demand.
As mentioned above, mental capacity or competence can be seen as decision-specific. With this in mind, one could argue for a context-sensitive threshold account where a person who doesn’t belong to any of the exemplary groups presented above still becomes momentarily incompetent, for example through distraction. Since many people get distracted sometimes, our rarity objection wouldn’t hold up in an account like that. Nevertheless, the relation between, say, momentary forgetfulness or distraction in a special context and cognitive enhancement is hard to measure – a person could be competent at a given moment due to cognitive enhancement, but also potentially due to the fact that she had a good night’s rest, she got helpful advice, or any other kind of circumstantial influence. We therefore want to present examples where links between general cognitive capacities (and their potential enhancements) and being above/below a competence threshold could be evaluated more clearly. We thank an anonymous reviewer for pressing us on this point.
Schaefer et al. discuss this potential objection in their footnote 7: “One might reply that, as a matter of fact, relatively few people are below the relevant threshold, so autonomy enhancement is not relevant to the vast population. But such a view would implausibly imply that very few acts of deception, manipulation, restriction, and so on actually reduce autonomy.” [1] We will assess deception and manipulation as relevant factors to inhibit autonomy in our last section. However, focusing on those as an objection to our point raised here disguises the problems contained in their approach related to the use of such widely accepted intuitive conceptions of autonomy. The statement that few people below a threshold might be helped through CE is not equal to the statement that few acts of deception reduce autonomy. Schaefer et al.’s argument depends on showing which forms of deception would be preventable through CE, and must refute the possibility that CE might pose an even greater risk of deception. Levin [49] has pointed out similar problems in Schaefer et al.’s reasoning.
Feinberg refers here to different notions of competence mentioned by Daniel Wikler. The sense mentioned above refers more to natural abilities than to legal powers. A conception of natural competence (“minimal relevant capacity for a task”) can also provide conditions to ascribe sovereign rights to individuals [37, p. 30]. Here we rather refer to a broader, or more natural understanding of a threshold conception of competence than to a legal one.
We do not want to claim that cognitive insight and therapies that provide such insight are not effective in helping patients but rather point to cases where the person has enough cognitive insight, yet does not reach the expected level of coherence.
We thank an anonymous reviewer for asking us to explore self-control as an executive function and a cognitive capacity more closely. Furthermore, Levin [49] discusses whether it is convincing to presume that reason is the source of higher order desires if lower order desires are only non-cognitive, and examines the relationship between them.
Pugh discusses some other misunderstandings of Habermas’ arguments by supporters of enhancement with regard to “the arguments of negative freedom” and “the argument from natality” [37, p. 30].
It should be noted that Levin attacks this line of reasoning, arguing that Schaefer et al. “isolate particular threads, for instance ‘deception and manipulation are bad,’ on which wide-ranging concurrence exists,” and thereby “they divert attention from highly controversial assumptions of their own.” [49, p. 61].
References
Schaefer, G.O., G. Kahane, and J. Savulescu. 2014. Autonomy and enhancement. Neuroethics 7(2): 123–136.
Habermas, J. 2003. The future of human nature. Cambridge: PolityPress.
Davis, D.S. 2009. The parental investment factor and the Child’s right to an open future. Hastings Center Report 39(2): 24–27.
Davis, D.S. 1997. Genetic dilemmas and the Child’s right to an open future. Hastings Center Report 27(2): 7–15.
Savulescu, J., R. ter Meulen, and G. Kahane. 2011. Enhancing human capacities. Chichester: Blackwell Publishing Ltd..
Bostrom, N., and A. Sandberg. 2009. Cognitive enhancement: methods, ethics, regulatory challenges. Science & Engineering Ethics 15(3): 311–341.
Housden, C.R., S. Morein-Zamir, and B.J. Sahakian. 2011. Cognitivie enhancing drugs: neuroscience and society. In Enhancing human capacities, ed. G. Kahane, J. Savulescu, and R. Ter Meulen, 113–126. Chichester: Wiley.
Persson, I., and J. Savulescu. 2008. The perils of cognitive enhancement and the urgent imperative to enhance the moral character of humanity. Journal of Applied Philosophy 25(3): 162–177.
Zohny, H. 2015. The myth of cognitive enhancement drugs. Neuroethics 8(3): 257–269.
Singh, I., I. Bard, and J. Jackson. 2014. Robust resilience and substantial interest: a survey of pharmacological cognitive enhancement among university students in the UK and Ireland. PloS One 9(10): e105969.
Quednow, B.B. 2010. Ethics of neuroenhancement. A phantom debate. BioSocieties 5(1): 153–156.
de Jongh, R., I. Bolt, M. Schermer, and B. Olivier. 2008. Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. Neuroscience & Biobehavioral Reviews 32(4): 760–776.
Lucke, J.C., S. Bell, B. Partridge, and W.D. Hall. 2011. Deflating the neuroenhancement bubble. American Journal of Bioethics Neuroscience 2(4): 38–43.
Hall, W.D., and J.C. Lucke. 2010. The enhancement use of Neuropharmaceuticals: more Scepticism and caution needed. Addiction 105(12): 2041–2043.
Lucke, J.C., S. Bell, B. Partridge, and W.D. Hall. 2010. Weak evidence for large claims contribute to the phantom debate. BioSocieties 5(4): 482–483.
Nadler, R.C., and P.B. Reiner. 2010. A call for data to inform discussion on cognitive enhancement. BioSocieties 5(4): 481–482.
McCabe, S.E., C.J. Teter, C.J. Boyd, J.R. Knight, and H. Wechsler. 2005. Nonmedical use of prescription opioids among US College students: prevalence and correlates from a National Survey. Addictive Behaviors 30(4): 789–805.
Maher, B. 2008. Poll results: look Who’s doping. Nature 452: 674–675.
Babcock, Q., and T. Byrne. 2000. Student perceptions of methylphenidate abuse at a public liberal arts college. Journal of American College Health 49(3): 143–145.
Franke, A.G., C. Bonertz, M. Christmann, M. Huss, A. Fellgiebel, E. Hildt, and K. Lieb. 2011. Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry 44(2): 60–66.
Wiegel, C., S. Sattler, A.S. Göritz, and M. Diewald. 2016. Work-related stress and cognitive enhancement among university teachers. Anxiety, Stress, and Coping 29(1): 100–117.
Bouchard, T.J., and M. McGue. 1981. Familial studies of intelligence: a review. Science 212(4498): 1055–1059.
Plucker, J.A., and A.L. Shelton. 2015. General intelligence (g): overview of a complex construct and its implications for genetics research. Hastings Center Report 45(S1): S21–S24.
Turkheimer, E. 2015. Genetic prediction. Hastings Center Report 45(S1): S32–S38.
Wray, N.R., J. Yang, B.J. Hayes, A.L. Price, M.E. Goddard, and P.M. Visscher. 2013. Pitfalls of predicting complex traits from SNPs. Nature Reviews Genetics 14(7): 507–515.
Tabery, J. 2015. Why is studying the genetics of intelligence so controversial? Hastings Center Report 45(S1): S9–S14.
McGue, M., and I.I. Gottesman. 2015. Classical and molecular genetic research on general cognitive ability. Hastings Center Report 45(S1): S25–S31.
Turkheimer, E. 2016. Weak genetic explanation 20 Years later: reply to Plomin et al. Perspectives on Psychological Science 11(1): 24–28.
Chabris, C.F., J.J. Lee, D. Cesarini, D.J. Benjamin, and D.I. Laibson. 2015. The fourth law of behavior genetics. Current Directions in Psychological Science 24(4): 304–312.
Davies, G., et al. 2015. Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N = 53949). Molecular Psychiatry 20(2): 183–192.
Burdick, K.E., T. Lencz, B. Funke, C.T. Finn, P.R. Szeszko, J.M. Kane, R. Kucherlapati, and A.K. Malhotra. 2006. Genetic variation in DTNBP1 influences general cognitive ability. Human Molecular Genetics 15(10): 1563–1568.
Deary, I.J., S.E. Harris, H.C. Fox, C. Hayward, A.F. Wright, J.M. Starr, and L.J. Whalley. 2005. KLOTHO genotype and cognitive ability in childhood and old age in the same individuals. Neuroscience Letters 378(1): 22–27.
Harris, S.E., H. Fox, A.F. Wright, C. Hayward, J.M. Starr, L.J. Whalley, and I.J. Deary. 2006. The brain-derived neurotrophic factor Val66Met polymorphism is associated with age-related change in reasoning skills. Molecular Psychiatry 11(5): 505–513.
Houlihan, L.M., S.E. Harris, M. Luciano, A.J. Gow, J.M. Starr, P.M. Visscher, and I.J. Deary. 2009. Replication study of candidate genes for cognitive abilities: the Lothian birth cohort 1936. Genes, Brain and Behavior 8(2): 238–247.
Rosoff, P.M. 2012. The myth of genetic enhancement. Theoretical Medicine and Bioethics 33(3): 163–178.
Sparrow, R. 2014. Better living through chemistry? A reply to Savulescu and Persson on ‘moral enhancement’. Journal of Applied Philosophy 31(1): 23–32.
Feinberg, J. 1986. Harm to self. New York: Oxford University Press.
Friedrich, O., and J.H. Heinrichs. 2014. Autonomie als Rechtfertigungsgrund Psychiatrischer Therapien. Ethik in der Medizin 26(4): 317–330.
Quante, M. 2011. In Defence of personal autonomy. Journal of Medical Ethics 37(10): 597–600.
Beauchamp, T., and J. Childress. 2009. Principles of biomedical ethics. Oxford: Oxford University Press.
Stewart, C., C. Peisah, and B. Draper. 2011. A test for mental capacity to request assisted suicide. Journal of Medical Ethics 37(1): 34–39.
Whalley, L.J., J.M. Starr, R. Athawes, D. Hunter, A. Pattie, and I.J. Deary. 2000. Childhood mental ability and dementia. Neurology 55(10): 1455–1459.
Deary, I.J., M.C. Whiteman, J.M. Starr, L.J. Whalley, and H.C. Fox. 2004. The impact of childhood intelligence on later life: following up the Scottish mental surveys of 1932 and 1947. Journal of Personality and Social Psychology 86(1): 130–147.
McGurn, B., I.J. Deary, and J.M. Starr. 2008. Childhood cognitive ability and risk of late-onset Alzheimer and vascular dementia. Neurology 71(14): 1051–1056.
Szymanski, L., and B.H. King. 1999. Practice parameters for the assessment and treatment of children, adolescents, and adults with mental retardation and comorbid mental disorders. Journal of the American Academy of Child & Adolescent Psychiatry 38(12): 5S–31S.
Kaufman, L., M. Ayub, and J.B. Vincent. 2010. The genetic basis of non-syndromic intellectual disability: a review. Journal of Neurodevelopmental Disorders 2(4): 182–209.
Khandaker, G.M., J.H. Barnett, I.R. White, and P.B. Jones. 2011. A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophrenia Research 132(2): 220–227.
Koenen, K.C., T.E. Moffitt, A.L. Roberts, L.T. Martin, L. Kubzansky, H.L. Harrington, R. Poulton, and A. Caspi. 2009. Childhood IQ and adult mental disorders: a test of the cognitive reserve hypothesis. American Journal of Psychiatry 166(1): 50–57.
Levin, S.B. 2016. Upgrading discussions of cognitive enhancement. Neuroethics 9(1): 53–67.
Elliott, C. 1998. The tyranny of happiness: ethics and cosmetic psychopharmacology. In Enhancing human traits: ethical and social implications, ed. E. Parens, 177–188. Washington D.C: Georgetown University Press.
Levy, N. 2011. Enhancing authenticity. Journal of Applied Philosophy 28(3): 308–318.
DeGrazia, D. 2000. Prozac, enhancement, and self-creation. Hastings Center Report 30(2): 34–40.
Wikler, D. 1979. Paternalism and the mildly retarded. Philosophy and Public Affairs 8(4): 377–392.
Frankfurt, H.G. 1971. Freedom of the will and the concept of a person. Journal of Philosophy 68(1): 5–20.
Dworkin, G. 1988. The theory and practice of autonomy. Cambridge: Cambridge University Press.
Young, R. 1989. Autonomy and the inner self. In The inner citadel: essays on individual autonomy, ed. J. Christman, 77–90. New York: Oxford University Press.
Richards, D.A.J. 1981. Rights and autonomy. Ethics 92(1): 3–20.
Shedler, J. 2010. The efficacy of psychodynamic psychotherapy. The American Psychologist 65(2): 98–109.
Mele, A. 2001. Autonomous Agents. New York: Oxford University Press.
Heilinger, J.C., and K. Crone. 2014. Human freedom and enhancement. Medicine, Health Care and Philosophy 17(1): 13–21.
Kant, I. 1997 [1785]. Grundlegung zur Metaphysik der Sitten [groundwork of the metaphysics of morals]. In Ak IV, ed. M. Gregor, 387–436. Cambridge: Cambridge University Press.
Oshana, M. 1998. Personal autonomy and society. Journal of Social Philosophy 29(1): 81–102.
Christman, J. 1991. Autonomy and personal history. Canadian Journal of Philosophy 21(1): 1–24.
Acknowledgement
We want to thank one of the anonymous reviewers who suggested to use the term “isolationism” instead of “reductionism”, which can be confusing given its common philosophical use. Our intention is to describe a problem encountered by the overlapping consensus method used by Schaefer et al. By extracting reasoning abilities as a core feature of very different accounts of autonomy, other relevant properties, conceptual ramifications, and potential real life consequences of these accounts can easily be blurred and disregarded.
Author information
Authors and Affiliations
Corresponding author
Additional information
Johannes Pömsl and Orsolya Friedrich have contributed equally.
Rights and permissions
About this article
Cite this article
Pömsl, J., Friedrich, O. Why Enhancing Autonomy Is Not a Question of Improving Single Aspects of Reasoning Abilities through Neuroenhancement. Neuroethics 10, 243–254 (2017). https://doi.org/10.1007/s12152-016-9299-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12152-016-9299-y